|
Real-time Estimate
Tradegate
16:02:37 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 14.10 EUR | +3.37% |
|
+10.46% | +173.78% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENFIT | Other Biotechnology & Medical Research | +5.28% | +10.46% | +173.78% | +283.14% | +341.03% | 840M |
-
|
-
|
-
|
- Stock Market
- Stocks
- GNFT Stock
- XUP Stock
- Charts GENFIT
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
